Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2019 | 3 |
2020 | 2 |
2022 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.
Cancers (Basel). 2022 Jun 12;14(12):2898. doi: 10.3390/cancers14122898.
Cancers (Basel). 2022.
PMID: 35740564
Free PMC article.
Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.
Rogado J, Pozo F, Troulé K, Sánchez-Torres JM, Romero-Laorden N, Mondejar R, Donnay O, Ballesteros A, Pacheco-Barcia V, Aspa J, Al-Shahrour F, Alfranca A, Colomer R.
Rogado J, et al. Among authors: donnay o.
Clin Transl Oncol. 2022 Nov;24(11):2241-2249. doi: 10.1007/s12094-022-02887-8. Epub 2022 Jul 23.
Clin Transl Oncol. 2022.
PMID: 35870091
Item in Clipboard
A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer.
Pacheco-Barcia V, Mondéjar Solís R, France T, Asselah J, Donnay O, Zogopoulos G, Bouganim N, Guo K, Rogado J, Martin E, Alcindor T, Colomer R.
Pacheco-Barcia V, et al. Among authors: donnay o.
Pancreas. 2019 May/Jun;48(5):e45-e47. doi: 10.1097/MPA.0000000000001294.
Pancreas. 2019.
PMID: 31090669
No abstract available.
Item in Clipboard
Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.
Rogado J, Romero-Laorden N, Sanchez-Torres JM, Ramos-Levi AM, Pacheco-Barcia V, Ballesteros AI, Arranz R, Lorenzo A, Gullon P, Garrido A, Serra López-Matencio JM, Donnay O, Adrados M, Costas P, Aspa J, Alfranca A, Mondejar R, Colomer R.
Rogado J, et al. Among authors: donnay o.
Oncoimmunology. 2020 Apr 16;9(1):1751548. doi: 10.1080/2162402X.2020.1751548. eCollection 2020.
Oncoimmunology. 2020.
PMID: 32363123
Free PMC article.
Item in Clipboard
Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents.
Pacheco-Barcia V, Mondéjar R, Martínez-Sáez O, Longo F, Moreno JA, Rogado J, Donnay O, Santander C, Carrato A, Colomer R.
Pacheco-Barcia V, et al. Among authors: donnay o.
Clin Colorectal Cancer. 2019 Sep;18(3):e287-e293. doi: 10.1016/j.clcc.2019.05.009. Epub 2019 Jun 8.
Clin Colorectal Cancer. 2019.
PMID: 31262698
Item in Clipboard
A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer.
Pacheco-Barcia V, Mondéjar Solís R, France T, Asselah J, Donnay O, Zogopoulos G, Bouganim N, Guo K, Rogado J, Martin E, Alcindor T, Colomer R.
Pacheco-Barcia V, et al. Among authors: donnay o.
Pancreatology. 2020 Mar;20(2):254-264. doi: 10.1016/j.pan.2019.12.010. Epub 2019 Dec 14.
Pancreatology. 2020.
PMID: 31866391
Item in Clipboard
Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy.
Llovet P, Sastre J, Ortega JS, Bando I, Ferrer M, García-Alfonso P, Donnay O, Carrato A, Jiménez A, Aranda E, León A, Grávalos C, Cámara JC, Feliú J, Sanchíz B, Caldés T, Díaz-Rubio E.
Llovet P, et al. Among authors: donnay o.
Mol Diagn Ther. 2015 Dec;19(6):397-408. doi: 10.1007/s40291-015-0165-0.
Mol Diagn Ther. 2015.
PMID: 26341080
Item in Clipboard
Cite
Cite